Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,104,608,254
-
Total 13F shares
-
28,934,930
-
Share change
-
-6,284,417
-
Total reported value
-
$510,413,878
-
Put/Call ratio
-
2188%
-
Price per share
-
$17.64
-
Number of holders
-
122
-
Value change
-
-$278,868,939
-
Number of buys
-
65
-
Number of sells
-
81
Institutional Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2025
As of 31 Dec 2025,
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) was held by
122 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,934,930 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Frazier Life Sciences Management, L.P., Clearbridge Investments, LLC, UBS Group AG, CITADEL ADVISORS LLC, FMR LLC, BAMCO INC /NY/, ADAR1 Capital Management, LLC, Rock Springs Capital Management LP, and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
122
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.